Targeting Cancer Stem Cells to Overcome Chemoresistance.
Toni NunesDiaddin HamdanChristophe LeboeufMorad El BouchtaouiGuillaume GapihanThi Thuy NguyenSolveig MelesEurydice AngeliPhilippe RatajczakHe LuMélanie Di BenedettoGuilhem BousquetAnne JaninPublished in: International journal of molecular sciences (2018)
Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant to most anti-cancer treatments and could be preferential targets to reverse this resistance, either targeting stemness pathways or cancer stem cell surface markers. Gold nanoparticles have emerged as innovative tools, particularly for photo-thermal therapy since they can be excited by laser to induce hyperthermia. Gold nanoparticles can be functionalized with antibodies to specifically target cancer stem cells. Preclinical studies using photo-thermal therapy have demonstrated the feasibility of targeting chemo-resistant cancer cells to reverse clinical chemoresistance. Here, we review the data linking cancer stem cells and chemoresistance and discuss the way to target them to reverse resistance. We particularly focus on the use of functionalized gold nanoparticles in the treatment of chemo-resistant metastatic cancers.
Keyphrases
- cancer stem cells
- gold nanoparticles
- cancer therapy
- papillary thyroid
- cell surface
- reduced graphene oxide
- single cell
- photodynamic therapy
- cell therapy
- squamous cell
- squamous cell carcinoma
- quantum dots
- combination therapy
- childhood cancer
- small cell lung cancer
- drug delivery
- stem cells
- mesenchymal stem cells
- machine learning
- replacement therapy
- epithelial mesenchymal transition